Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Nieuw alzheimermiddel eerste wetenschappelijke succes in lange tijd
mrt 2023 | Dementie